Biologic Therapeutic Drugs: Technologies and Global Markets

Report Scope:
 
The current report offers a detailed picture of the biologics market.
 
This report highlights the current and future market potential for biologics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2025, as well as key market players.
 
This report details market shares for biologics based on product and geography. Based on product, the market is segmented into therapeutic proteins, vaccines and other segments.
 
Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2020 as the base year, with forecasts for 2020 through 2025. Estimated values are based on product manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.
 
Report Includes:
 
- 22 data tables and 26 additional tables
- An overview of the global market for biologic therapeutic drugs
- Analyses of the global market trends, with data from 2018-2020, and projections of compound annual growth rates (CAGRs) through 2025
- Evaluation of market size and market forecast; and detailed review of drivers, challenges, and opportunities affecting the global market growth
- Detailed description of product segments of biologic therapeutic drugs, such as therapeutic proteins, vaccines, cell therapy, gene therapy, blood plasma products, and others
- Assessment of the competitive environment, with a special focus on how new products and technologies are influencing the current standards of care
- Country specific data and analysis for the United States, Canada, Germany, U.K., France, Italy, Spain, Russia, China, India, Japan and other emerging economies
- Impact analysis of COVID-19 on the entire life sciences industry as well as on biologic therapeutic drugs market
- Profiles of current market leaders, as well as companies with innovative products poised to advance within the forecast period
- Company profile descriptions of major biologic therapeutic drugs manufacturers, including Amgen Inc., Baxter International, CSL Ltd., Eli Lilly and Co., F. Hoffmann-La Roche, GlaxoSmithKline Plc, Novartis and Sanofi.

Summary:
 
The global market for biologic therapeutic drugs was valued at $REDACTED in 2019. The market is expected to grow at a compound annual growth rate (CAGR) of REDACTED% to reach $REDACTED by 2025. Growth of the global market is attributed to the rising prevalence of chronic and acute diseases and the growing global geriatric population.
 
The global biologic therapeutic drug market is segmented in this report by product and region.
 
Reasons for Doing This Study:
 
The biologics market is wide ranging and has important implications for the future of medicine and industry advancement. For companies with an effective strategy, market opportunities await. Importantly, the ability to develop an effective strategy begins where opportunity exists and ends with how to effectively execute a plan to capture profit from such opportunities.
 
Market growth has been spurred by the need for a more extensive pipeline from drug companies, attractive targets against challenging diseases, a push by companies to pursue biosimilars (a biologic like another biologic that has already been authorized for use) and manufacturing technologies that reduce the cost to produce profitable products.
 
This report seeks to address the critically important topics of changing market dynamics, emerging players and technologies, strategies for accessing emerging markets, and specific disease segments and geographies to allocate resources and make effective decisions.

 Chapter 1 Introduction
 Introduction
 Study Goals and Objectives
 Reasons for Doing This Study
 Scope of Report
 Information Sources
 Methodology
 Geographic Breakdown
 Analysts Credentials
 BCC Custom Research
 Related BCC Research Reports
 Chapter 2 Summary and Highlights
 Chapter 3 Market and Technology Background
 
Biopharmaceutical Industry Structure
 Origins of Biotechnology
 Involvement of Large Pharmaceutical Companies
 Overview of Biologics
 Biologics Manufacturing
 Biopharmaceutical Manufacturing Process
 The Preparation Process
 Expression Systems for Therapeutic Protein Production
 E. coli Advantages for Microbial Production
 Mammalian Cell Therapeutic Protein Production
 FDA Regulation of Biologics
 Chapter 4 Impact of COVID-19 Pandemic
 
Introduction
 Short-Term Impact
 Long-Term Impact
 Delayed Approvals for Non-COVID-Related Pharmaceutical Products
 Self-Sufficiency in Pharma Industry
 Progression of COVID-19
 Government Expenditures on COVID-19
 Social Impact of COVID-19
 Impact on Insurance Providers
 Impact on Health Technology Assessment
 Changes in Consumption Trends in Health-Related Products
 Chapter 5 Market Dynamics
 
Market Drivers
 Overview
 Rising Prevalence of Chronic Diseases
 Advancement in Biologics
 Growing Geriatric Population
 Market Restraints
 Emergence of Biosimilars
 Market Opportunities
 Opportunities in Emerging Nations
 Chapter 6 Market Breakdown by Product Segment
 
Global Market for Biologic Therapeutic Drugs by Product Segment
 Therapeutic Proteins
 Vaccines
 Others
 Chapter 7 Market Breakdown by Region
 
Global Market for Biologic Therapeutic Drugs by Region
 North America
 Europe
 Asia-Pacific
 Latin America
 Middle East and Africa
 Chapter 8 Competitive Landscape
 
Porters Five Forces Analysis
 Bargaining Power of Suppliers
 Bargaining Power of Buyers
 Threat of New Entrants
 Threat of Substitutes
 Competitive Rivalry/Degree of Competition
 Chapter 9 Company Profiles
 
AMGEN INC.
 BAXTER
 CHINA BIOLOGIC PRODUCTS INC.
 CSL LTD.
 DENDREON PHARMACEUTICALS LLC
 ELI LILLY AND CO.
 F. HOFFMANN-LA ROCHE LTD.
 GLAXOSMITHKLINE PLC
 GLYCOTOPE GMBH
 GRIFOLS S.A.
 JSC PHARMSTANDARD
 KEDRION S.P.A.
 NOVARTIS AG
 OCTAPHARMA AG
 RELIANCE LIFE SCIENCES
 SANOFI
 TEVA PHARMACEUTICAL INDUSTRIES LTD.


List Of Tables

 Summary Table : Global Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
 Table 1 : Biologic Orphan Drugs, by Trade Name and Indication
 Table 2 : Expenditures on COVID-19 Crisis, by Selected Country
 Table 3 : Interim Economic Outlook Forecasts, by Country/Region, 2019-2021
 Table 4 : Number and Distribution of Persons Aged 60 and Over, by Region, 2017 and 2050
 Table 5 : Global Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
 Table 6 : Global Market for Biologic Therapeutic Proteins, by Region, Through 2025
 Table 7 : Global Market for Biologics Therapeutic Vaccines, by Region, Through 2025
 Table 8 : Global Market for Other Biologic Therapeutic Drug Products, by Region, Through 2025
 Table 9 : Global Market for Biologic Therapeutic Drugs, by Region, Through 2025
 Table 10 : North American Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
 Table 11 : North American Market for Biologic Therapeutic Drugs, by Country, Through 2025
 Table 12 : European Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
 Table 13 : European Market for Biologic Therapeutic Drugs, by Country, Through 2025
 Table 14 : Asia-Pacific Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
 Table 15 : Asia-Pacific Market for Biologic Therapeutic Drugs, by Country, Through 2025
 Table 16 : Japanese Market Statistics
 Table 17 : Latin American Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
 Table 18 : Middle Eastern and African Market for Biologic Therapeutic Drugs, by Product Segment, Through 2025
 Table 19 : Porters Five Forces Analysis
 Table 20 : Amgen Inc.: Product Portfolio
 Table 21 : Baxter: Product Portfolio
 Table 22 : Baxter: Recent Developments, 2021
 Table 23 : China Biologic Products Holdings Inc.: Product Portfolio
 Table 24 : China Biologic Products Holdings Inc.: Pipeline Plasma Products
 Table 25 : China Biologic Products Holdings Inc.: Recent Developments, 2017
 Table 26 : CSL Ltd.: Products Portfolio
 Table 27 : CSL Ltd.: Recent Developments, 2021
 Table 28 : Dendreon Pharmaceuticals LLC: Product Portfolio
 Table 29 : Eli Lilly and Co.: Product Portfolio
 Table 30 : F. Hoffmann-La Roche Ltd.: Financials, 2019
 Table 31 : F. Hoffmann-La Roche Ltd.: Revenues, by Business Segment, 2016-2018
 Table 32 : F. Hoffmann-La Roche Ltd.: Product Portfolio
 Table 33 : GlaxoSmithKline Plc: Financials, 2017-2019
 Table 34 : GlaxoSmithKline Plc: Products and Services
 Table 35 : Glycotope GmbH: Product Portfolio
 Table 36 : Grifols S.A.: Product Portfolio
 Table 37 : Grifols S.A.: Recent Developments, 2020
 Table 38 : JSC Pharmstandard: Product Portfolio
 Table 39 : Kedrion S.p.A.: Products and Services
 Table 40 : Kedrion S.p.A.: Developments and Strategies
 Table 41 : Novartis AG: Product Portfolio
 Table 42 : Octapharma AG: Products and Services
 Table 43 : Octapharma AG: Recent Developments, 2020
 Table 44 : Reliance Life Sciences: Product Portfolio
 Table 45 : Sanofi: Products and Services
 Table 46 : Teva Pharmaceutical Industries Ltd.: Product Portfolio
 Table 47 : Teva Pharmaceutical Industries Ltd.: Financials, 2017-2019
  


List Of Figures

Summary Figure : Global Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 1 : Impact of COVID-19 on the Pharmaceutical Industry
Figure 2 : Comparison of GDP Growth, by Country, 2019 and 2020
Figure 3 : Global Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 4 : Global Market for Biologic Therapeutic Proteins, 2018-2025
Figure 5 : Global Market for Biologic Therapeutic Proteins, by Region, 2018-2025
Figure 6 : Global Market for Biologics Therapeutic Vaccines, 2018-2025
Figure 7 : Global Market for Biologics Therapeutic Vaccines, by Region, 2018-2025
Figure 8 : Global Market for Other Biologic Therapeutic Drug Products, 2018-2025
Figure 9 : Global Market for Other Biologic Therapeutic Drug Products, by Region, 2018-2025
Figure 10 : Global Market for Biologic Therapeutic Drugs, by Region, 2018-2025
Figure 11 : Global Market Shares of Biologic Therapeutic Drugs, by Region, 2019
Figure 12 : North American Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 13 : North American Market Shares of Biologic Therapeutic Drugs, by Country, 2019
Figure 14 : U.S. Market for Biologic Therapeutic Drugs, 2018-2025
Figure 15 : Canadian Market for Biologic Therapeutic Drugs, 2018-2025
Figure 16 : European Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 17 : European Market Shares of Biologic Therapeutic Drugs, by Country, 2019
Figure 18 : German Market for Biologic Therapeutic Drugs, 2018-2025
Figure 19 : U.K. Market for Biologic Therapeutic Drugs, 2018-2025
Figure 20 : French Market for Biologic Therapeutic Drugs, 2018-2025
Figure 21 : Italian Market for Biologic Therapeutic Drugs, 2018-2025
Figure 22 : Spanish Market for Biologic Therapeutic Drugs, 2018-2025
Figure 23 : Rest of European Market for Biologic Therapeutic Drugs, 2018-2025
Figure 24 : Asia-Pacific Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 25 : Asia-Pacific Market Shares of Biologic Therapeutic Drugs, by Country, 2019
Figure 26 : Chinese Market for Biologic Therapeutic Drugs, 2018-2025
Figure 27 : Japanese Market for Biologic Therapeutic Drugs, 2018-2025
Figure 28 : Indian Market for Biologic Therapeutic Drugs, 2018-2025
Figure 29 : Rest of Asia-Pacific Market for Biologic Therapeutic Drugs, 2018-2025
Figure 30 : Latin American Market for Biologic Therapeutic Drugs, 2018-2025
Figure 31 : Latin American Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 32 : Middle Eastern and African Market for Biologic Therapeutic Drugs, 2018-2025
Figure 33 : Middle Eastern and African Market Shares of Biologic Therapeutic Drugs, by Product Segment, 2019
Figure 34 : Amgen Inc.: Annual Revenue, 2015-2019
Figure 35 : Amgen Inc.: Revenue Share, by Country, 2019
Figure 36 : Baxter: Annual Revenue, 2015-2019
Figure 37 : Baxter: Revenue Share, by Business Unit, 2019
Figure 38 : Baxter: Revenue Share, by Region, 2019
Figure 39 : China Biologic Products Holdings Inc.: Financials, 2015-2019
Figure 40 : China Biologic Products Holdings Inc.: Revenue Share, by Segment, 2019
Figure 41 : CSL Ltd.: Financials, 2015-2019
Figure 42 : CSL Ltd.: Revenue Share, by Segment, 2019
Figure 43 : CSL Ltd.: Revenue Share, by Country/Region, 2019
Figure 44 : Eli Lilly and Co.: Annual Revenue, 2017-2019
Figure 45 : Eli Lilly and Co.: Revenue Share, by Region, 2019
Figure 46 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Segment, 2019
Figure 47 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, 2019
Figure 48 : GlaxoSmithKline Plc: Revenue Share, by Business Segment, 2019
Figure 49 : GlaxoSmithKline Plc: Revenue Share, by Region, 2019
Figure 50 : Grifols S.A.: Financials, 2015-2019
Figure 51 : Grifols S.A.: Revenues Share, by Segment, 2019
Figure 52 : Grifols S.A.: Revenue Share, by Region, 2019
Figure 53 : Kedrion S.p.A.: Financials, 2015-2019
Figure 54 : Kedrion S.p.A.: Revenue Share, by Segment, 2019
Figure 55 : Kedrion S.p.A.: Revenue Share, by Region, 2019
Figure 56 : Novartis AG.: Annual Revenue, 2015-2019
Figure 57 : Novartis AG: Revenue Share, by Region, 2019
Figure 58 : Novartis AG: Revenue Share, by Business Segment, 2019
Figure 59 : Octapharma AG: Financials, 2015-2019
Figure 60 : Octapharma AG: Revenue, by Operating Income, 2015-2019
Figure 61 : Sanofi: Annual Revenue, 2017-2019
Figure 62 : Sanofi: Revenue Share, by Business Segment, 2019
Figure 63 : Sanofi: Revenue Share, by Region, 2019
Figure 64 : Teva Pharmaceutical Industries Ltd.: Revenue Share, by Region, 2019

Companies Mentioned
AMGEN INC.
BAXTER
CHINA BIOLOGIC PRODUCTS INC.
CSL LTD.
DENDREON PHARMACEUTICALS LLC
ELI LILLY AND CO.
F. HOFFMANN-LA ROCHE LTD.
GLAXOSMITHKLINE PLC
GLYCOTOPE GMBH
GRIFOLS S.A.
JSC PHARMSTANDARD
KEDRION S.P.A.
NOVARTIS AG
OCTAPHARMA AG
RELIANCE LIFE SCIENCES
SANOFI
TEVA PHARMACEUTICAL INDUSTRIES LTD.


Global Biologics Safety Testing Market – Analysis By Product, Test, Application, By Region, By Country (2021 Edition): Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)

Executive Global Biologics Safety Testing Market was valued at USD 3463.90 Million in the year 2020. Major factors driving the growth of this market are the growth in pharmaceutical and

USD 2400 View Report

Biologic Therapeutic Drugs: Technologies and Global Markets

Biologic Therapeutic Drugs Industry. global Biologic Therapeutic Drugs market trends, with data from 2018 and 2019, and projections of CAGRs through 2024. market research report available in single user pdf license with Aarkstore Enterprise at USD 5500

USD 5500 View Report

North America Biologic Therapeutics Drugs Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The North America Biologic Therapeutics Drugs market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD

USD 3000 View Report

North America Biologic Therapeutics Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The North America Biologic Therapeutics market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available